<?xml version="1.0" encoding="UTF-8"?>
<p>To compare the inhibitory effect of the anti-DENV 1C19 scFv to DENV inhibition through 
 <italic>Wolbachia</italic>[
 <xref rid="ppat.1008103.ref065" ref-type="bibr">65</xref>â€“
 <xref rid="ppat.1008103.ref067" ref-type="bibr">67</xref>] infection, we challenged WT mosquitoes infected with 
 <italic>Wolbachia</italic> (
 <italic>w</italic>Mel) with DENV-2. Vector competence results revealed that midguts from mosquitoes infected with 
 <italic>Wolbachia</italic> had significantly (
 <italic>p</italic> &lt; 0.001) reduced DENV-2 RNA levels (4.75 x 10
 <sup>1</sup> GE) at 4 dpi compared with the WT (4.25 x 10
 <sup>4</sup> GE) (
 <xref ref-type="fig" rid="ppat.1008103.g001">Fig 1B</xref>, 
 <xref rid="ppat.1008103.t001" ref-type="table">Table 1</xref>). Similarly, viral dissemination at 14 dpi was also reduced (
 <italic>p</italic> &lt; 0.001) in 
 <italic>w</italic>Mel mosquitoes (~3 log
 <sub>10</sub>), and DENV titers in mosquito saliva at 14 dpi were significantly (
 <italic>p</italic> &lt; 0.01) lower (~3 log
 <sub>10</sub>) in 
 <italic>w</italic>Mel mosquitoes (4.90 x 10
 <sup>1</sup> TCID
 <sub>50</sub>/ml/mosquito) than in the WT (2.70 x 10
 <sup>5</sup> TCID
 <sub>50</sub>/ml/mosquito) (
 <xref ref-type="fig" rid="ppat.1008103.g001">Fig 1B</xref>, 
 <xref rid="ppat.1008103.t001" ref-type="table">Table 1</xref>). Importantly, a direct comparison revealed that the TADV-A mosquitoes are significantly (
 <italic>p</italic> &lt; 0.001) more effective as homozygotes, and similarly effective as heterozygotes, at blocking DENV infection as 
 <italic>Wolbachia</italic>-infected mosquitoes.
</p>
